The COLON Study: Colorectal Cancer Cohort

Sponsor
Wageningen University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03191110
Collaborator
Dutch Cancer Society (Other), Wereld Kanker Onderzoek Fonds (Other), Funding: World Cancer Research Fund International (Other), Funding: ERA-NET on Translational Cancer Research (TRANSCAN) (Other)
2,000
11
243.9
181.8
0.7

Study Details

Study Description

Brief Summary

The main aim of this observational, prospective cohort study is to assess associations of diet and other lifestyle factors with colorectal cancer recurrence, survival and quality of life.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention: observational study

Detailed Description

The COLON study is a multi-centre prospective cohort study among incident colorectal cancer patients recruited from 12 hospitals in the Netherlands. Patients with colorectal cancer are invited upon diagnosis. Upon recruitment, after 6 months, 2 years and 5 years, patients fill out food-frequency questionnaires; questionnaires about dietary supplement use, physical activity, weight, height, and quality of life; and donate blood samples. Diagnostic CT-scans are collected to assess cross-sectional areas of skeletal muscle, subcutaneous fat, visceral fat and intermuscular fat, and to assess muscle attenuation. Blood samples are biobanked to facilitate future analyse of biomarkers, nutrients, DNA etc. Analysis of serum 25-hydroxy vitamin D levels, B-vitamins and metabolomic profiles are scheduled. A subgroup of patients with colon cancer is asked to provide faecal samples before and at several time points after colon resection to study changes in gut microbiota during treatment. For all patients, information on vital status is retrieved by linkage with national registries. Information on clinical characteristics, including treatment-related toxicity and co-morbidity data, is gathered from linkage with the Netherlands Cancer Registry and with hospital databases or medical records. Hazard ratios will be calculated for dietary and lifestyle factors at diagnosis in relation to recurrence and survival. Repeated measures analyses will be performed to assess changes over time in dietary and other factors in relation to recurrence and survival.

The aim is to recruit at least 2000 patients with available data and blood samples.

Study Design

Study Type:
Observational
Anticipated Enrollment :
2000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The COLON Study: Colorectal Cancer: Longitudinal, Observational Study on Nutritional and Lifestyle Factors That May Influence Colorectal Tumour Recurrence, Survival and Quality of Life
Actual Study Start Date :
Aug 3, 2010
Anticipated Primary Completion Date :
Dec 1, 2030
Anticipated Study Completion Date :
Dec 1, 2030

Arms and Interventions

Arm Intervention/Treatment
Colorectal cancer patients

Other: No intervention: observational study

Outcome Measures

Primary Outcome Measures

  1. Survival [An average follow-up of at least 5 years]

    Overall survival

  2. Cancer recurrence [An average follow-up of at least 5 years]

    Cancer recurrence

  3. Quality of life (EORTC QLQ-C30) [An average follow-up of at least 5 years]

    Quality of life

Secondary Outcome Measures

  1. Chemotherapy-induced toxicity (QLQ-CIPN20) [12 months after diagnosis]

    Chemotherapy-induced peripheral neuropathy

  2. Microbiota composition based on 16S rRNA profiling [At diagnosis and 6, 12 and 35 weeks after resection]

    Stool samples

  3. Co-morbidities [An average follow-up of at least 5 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients newly diagnosed with colorectal cancer in one of the participating hospitals
Exclusion Criteria:
  • Non-Dutch speaking

  • A history of colorectal cancer or (partial) bowel resection

  • Chronic inflammatory bowel disease

  • Hereditary colorectal cancer syndromes (Lynch syndrome, FAP, Peutz-Jegher)

  • Dementia or another mental condition that makes it impossible to fill out questionnaires

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ziekenhuisgroep Twente Almelo Netherlands
2 Gelre Hospital Apeldoorn Netherlands
3 Rijnstate Hospital Arnhem Netherlands
4 Slingeland Hospital Doetinchem Netherlands
5 Hospital Gelderse Vallei Ede Netherlands
6 Admiraal De Ruyter Hospital Goes/Vlissingen Netherlands
7 Martini Hospital Groningen Netherlands
8 Canisius Wilhelmina Hospital Nijmegen Netherlands
9 Radboudumc Nijmegen Netherlands
10 Bernhoven Hospital Oss Netherlands
11 Isala Klinieken Zwolle Netherlands

Sponsors and Collaborators

  • Wageningen University
  • Dutch Cancer Society
  • Wereld Kanker Onderzoek Fonds
  • Funding: World Cancer Research Fund International
  • Funding: ERA-NET on Translational Cancer Research (TRANSCAN)

Investigators

  • Principal Investigator: Ellen Kampman, PhD, Wageningen University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Wageningen University
ClinicalTrials.gov Identifier:
NCT03191110
Other Study ID Numbers:
  • NL30446.091.09
  • CMO number 2009/349
First Posted:
Jun 19, 2017
Last Update Posted:
Oct 9, 2018
Last Verified:
Oct 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wageningen University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 9, 2018